Zhi Peng
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 35
- Colorectal Cancer Treatments and Studies 21
- Pancreatic and Hepatic Oncology Research 18
- HER2/EGFR in Cancer Research 11
- Gastroenterology top 5%
-
- Gastric Cancer Management and Outcomes 38
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 9
- Hepatology top 5%
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 11
-
- Neuroendocrine Tumor Research Advances 9
- Co-authors
- Lin ShenJifang GongXiaotian ZhangMing LuJian LiJun ZhouXicheng WangZhihao Lü
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Zhi Peng
100 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 103
- Oncology 1.3k
- Gastroenterology 146
- Pulmonary and Respiratory Medicine 669
- Cancer Research 224
- Hepatology 117
Countries citing papers authored by Zhi Peng
This map shows the geographic impact of Zhi Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Peng more than expected).
Fields of papers citing papers by Zhi Peng
This network shows the impact of papers produced by Zhi Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Peng. The network helps show where Zhi Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhi Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 40 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 37 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 75 | |
| 10 | 2021 | 21 | |
| 11 | 2021 | 7 | |
| 12 | 2020 | 235 | |
| 13 | 2020 | 26 | |
| 14 | 2020 | 15 | |
| 15 | 2020 | 54 | |
| 16 | 2019 | 62 | |
| 17 | 2018 | 46 | |
| 18 | 2017 | 18 | |
| 19 | 2017 | 37 | |
| 20 | 2015 | 19 |
About Zhi Peng
Zhi Peng is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 106 papers that have together received 2.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (38 papers), Cancer Immunotherapy and Biomarkers (35 papers), Colorectal Cancer Treatments and Studies (21 papers), Pancreatic and Hepatic Oncology Research (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), HER2/EGFR in Cancer Research (11 papers), Cancer Genomics and Diagnostics (9 papers) and Neuroendocrine Tumor Research Advances (9 papers). The work is most often cited by research in Oncology (1.3k citations), Gastroenterology (146 citations) and Pulmonary and Respiratory Medicine (669 citations). Zhi Peng has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Lin Shen, Jifang Gong, Lin Shen, Xiaotian Zhang, Ming Lu, Jian Li, Jun Zhou, Xicheng Wang, Zhihao Lü and Changsong Qi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.